pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 3
    soquelitinib
    soquelitinib
    Peripheral T-Cell Lymphomas (PTCL)$CRVS Corvus Pharmaceuticals, Inc.1 cat
  • Phase 2
    toripalimab
    Loqtorzi (toripalimab-tpzi)
    Esophageal Squamous Cell Carcinoma (ESCC)$CHRS Coherus Oncology, Inc.1 cat
  • Phase 3
    tremelimumab
    Imjudo (tremelimumab-actl)
    Small-Cell Lung Cancer$AZN ASTRAZENECA PLC1 cat
← prev
page 6 of 62
next →
Pain89
Neurology1
Phase 2
ubidecarenone
ubidecarenone [INN]
Metastatic Adenocarcinoma of The Pancreas
BPGbio Inc
1 cat
  • Marketed
    zanubrutinib
    Brukinsa (zanubrutinib)
    Membranous Glomerulonephritis$ONC BeOne Medicines Ltd.1 cat
  • Phase 2
    (atigotatug + nivolumab)
    (atigotatug [INN] + nivolumab)
    Small-Cell Lung Cancer Bristol-Myers Squibb Co
  • Phase 3
    (azacitidine + cedazuridine)
    (azacitidine + cedazuridine)
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Taiho Oncology Inc
  • Marketed
    (betamethasone acetate + betamethasone sodium phosphate)
    Celestone Soluspan ((betamethasone acetate + betamethasone sodium phosphate))
    Cerebral Edema$OGN Organon & Co.
  • Preclinical
    (calcipotriene + fluorouracil)
    (calcipotriene + fluorouracil)
    Cutaneous Squamous Cell Carcinoma (cSCC) Phd Skin Care LLC
  • Preclinical
    (cannabidivarin + cannabigerolic acid)
    Colorectal Cancer$CNBX CNBX Pharmaceuticals Inc.
  • Marketed
    (cedazuridine + decitabine)
    Inqovi ((cedazuridine + decitabine))
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Otsuka Pharmaceutical Co Ltd
  • Phase 3
    (cisplatin + vinblastine sulphate)
    (cisplatin + vinblastine sulphate)
    Dedifferentiated Liposarcoma$INTS INTENSITY THERAPEUTICS, INC.
  • Marketed
    (cytarabine hydrochloride + daunorubicin hydrochloride)
    Vyxeos ((cytarabine hydrochloride + daunorubicin hydrochloride))
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)$JAZZ Jazz Pharmaceuticals plc
  • Phase 2
    (docetaxel + gemcitabine) SR
    (docetaxel + gemcitabine)
    Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…$RLMD RELMADA THERAPEUTICS, INC.
  • Preclinical
    (gemcitabine + paclitaxel)
    (gemcitabine+ paclitaxel)
    Pancreatic Ductal Adenocarcinoma Duo Oncology Inc
  • Marketed
    (hyaluronidase (recombinant human) + pertuzumab + trastuzumab)
    Phesgo ((hyaluronidase-zzxf (recombinant human) + pertuzumab + trastuzumab))
    Human Epidermal Growth Factor Receptor 2 Positive Breast… Genentech Inc
  • Marketed
    (hyaluronidase (recombinant, human) + rituximab)
    Rituxan Hycela ((hyaluronidase (recombinant, human) + rituximab))
    Chronic Lymphocytic Leukemia (CLL) Genentech Inc
  • Marketed
    (hyaluronidase (recombinant, human) + trastuzumab)
    Herceptin Hylecta ((hyaluronidase-oysk (recombinant, human) + trastuzumab))
    Breast Cancer Genentech Inc
  • Phase 2
    (nanatinostat + valganciclovir)
    (nanatinostat + valganciclovir [INN])
    Post-Transplant Lymphoproliferative Disorder Viracta Therapeutics Inc
  • Marketed
    (nivolumab + relatlimab)
    Opdualag ((nivolumab + relatlimab-rmbw))
    Metastatic Melanoma Bristol-Myers Squibb Co
  • Phase 2
    (prednisone + valproate sodium)
    (prednisone [INN] + valproate sodium)
    Diffuse Large B-Cell Lymphoma Respiratorius AB
  • Phase 2
    (senaparib + temozolomide)
    (senaparib [INN] + temozolomide)
    Small-Cell Lung Cancer IMPACT Therapeutics Inc
  • Marketed
    (tipiracil hydrochloride + trifluridine)
    Lonsurf ((tipiracil hydrochloride + trifluridine))
    Adenocarcinoma Of The Gastroesophageal Junction Taiho Oncology Inc
  • Preclinical
    15d-PMJ2
    Colon Cancer Claradele Pharmaceuticals Inc
  • Phase 2
    177Lu-LNC-1011
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Yantai Lannacheng Biotechnology Co Ltd
  • Preclinical
    188-RNLBAM
    Hepatocellular Carcinoma$PSTV PLUS THERAPEUTICS, INC.
  • Phase 1
    212Pb-GRPR
    Cervical Cancer Orano Med LLC
  • Preclinical
    212Pb-LNC-1011
    Prostate Cancer Yantai Lannacheng Biotechnology Co Ltd
  • Preclinical
    3D-059
    Unspecified Cancer$SLS SELLAS Life Sciences Group, Inc.
  • Preclinical
    3D-062
    Unspecified Cancer 3D Medicines Inc